277 related articles for article (PubMed ID: 2478482)
1. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
[TBL] [Abstract][Full Text] [Related]
2. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
[TBL] [Abstract][Full Text] [Related]
3. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
[TBL] [Abstract][Full Text] [Related]
4. [Effect of hemodilution on systemic and capillary hematocrit].
Jung F; Koscielny J; Mrowietz C; Wolf S; Kiesewetter H; Wenzel E
Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
[TBL] [Abstract][Full Text] [Related]
5. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
Jung F; Waldhausen P; Spitzer S; Wenzel E
Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
[TBL] [Abstract][Full Text] [Related]
6. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
[TBL] [Abstract][Full Text] [Related]
7. [Effect of an infusion with middle molecular weight hydroxyethyl starch (HAES-steril 10%) on the flow properties of blood in healthy probands].
Landgraf H; Ehrly AM; Saeger-Lorenz K; Vogel C
Infusionsther Klin Ernahr; 1981 Aug; 8(4):200-4. PubMed ID: 6168586
[TBL] [Abstract][Full Text] [Related]
8. [Conjunctival oxygen partial pressure, hemorheology and circulatory parameters in acute cerebral infarct before and following infusion of 6 percent low molecular hydroxyethyl starch].
Kortsik CS; Staedt U; Stein T; Geiger G; Buss J
Infusionstherapie; 1990 Apr; 17(2):79-82. PubMed ID: 1693909
[TBL] [Abstract][Full Text] [Related]
9. [Improvement of the flow properties of the blood of patients by low-molecular hydroxyethyl starch (Expafusin)].
Landgraf H; Ruppel C; Saeger-Lorenz K; Vogel C; Ehrly AM
Infusionsther Klin Ernahr; 1982 Aug; 9(4):202-6. PubMed ID: 6182099
[TBL] [Abstract][Full Text] [Related]
10. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
11. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
12. [Middle-molecular hydroxyethyl starch as a volume substitute. Its rheological effect in peripheral arterial occlusive diseases].
Kiesewetter H; Blume J; Bulling B; Gerhards M; Jung F; Radtke H; Franke RP
Dtsch Med Wochenschr; 1984 Nov; 109(48):1844-7. PubMed ID: 6209081
[TBL] [Abstract][Full Text] [Related]
13. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
[TBL] [Abstract][Full Text] [Related]
15. Hemorrheological, micro- and macrocirculatory effects of naftidrofuryl in an acute study: a randomized, placebo-controlled, double-blind individual comparison.
Jung F; Kiesewetter H; Mrowietz C; Leipnitz G; Braun B; Wappler M; Scheffler P; Wenzel E
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):507-14. PubMed ID: 3679623
[TBL] [Abstract][Full Text] [Related]
16. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study on the effect of hydroxyethyl starch on erythrocyte aggregation and microcirculation].
Zhang YJ
Zhonghua Wai Ke Za Zhi; 1982 Jul; 20(7):401-2. PubMed ID: 6184206
[No Abstract] [Full Text] [Related]
18. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
Brehme S; Keysser G; Turowski A; Schmidt HH
Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
[TBL] [Abstract][Full Text] [Related]
19. [Intra- and postoperative effect of different hydroxyethyl starch solutions on the flow properties of the blood and on the oxygen partial pressure of the conjunctiva].
Tormann T; Jung F; Simon J; Schwerdtfeger K; Kiesewetter H; Racenberg E
Anaesthesist; 1990 Mar; 39(3):166-72. PubMed ID: 1691900
[TBL] [Abstract][Full Text] [Related]
20. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers.
Ehrly AM; Landgraf H
Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]